PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 15282910

Governing genetics: reifying choice and progress.

Anne Kerr
View original source ↗Export metadata ↓

Abstract

The governance of genetics involves a wide range of policy networks and covers a considerable array of genetic technoscience. Despite this apparent diversity, the uniformity of some genetic governance requires investigation. Reviewing policy documents on genetic patenting and embryonic stem cell research, I shall argue that policy networks often conceive of the ethical aspects of these practices in similar ways. In particular, I shall argue that individual choice and medico-scientific progress are common rhetorical devices in their frameworks. I shall end by commenting upon the implications of these trends for the future.

Explore related subjects

Advisory CommitteesBase SequenceCloning, OrganismEmbryo ResearchEmbryo, MammalianEuropeGenesGenetic ResearchHumansInternationalityPatents as TopicPolicy MakingSocial Control, FormalStem CellsUnited KingdomBiomedical and Behavioral ResearchEuropean Group on Ethics in Science and New TechnologiesGenetics and ReproductionLegal ApproachNuffield Council on BioethicsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Anne Kerr. 2003. Governing genetics: reifying choice and progress.. https://doi.org/10.1080/1463677032000102611

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2022

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.

Since the publication of the Revised European-American Classification of Lymphoid Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have been generated through iterative international efforts to achieve broad consensus among hematopathologists, geneticists, molecular scientists, and clinicians. Significant progress has recently been made in the characterization of malignancies of the immune system, with many new insights provided by genomic studies. They have led to this proposal. We have followed the same process that was successfully used for the third and fourth editions of the World Health Organization Classification of Hematologic Neoplasms. The definition, recommended studies, and criteria for the diagnosis of many entities have been extensively refined. Some categories considered provisional have now been upgraded to definite entities. Terminology for some diseases has been revised to adapt nomenclature to the current knowledge of their biology, but these modifications have been restricted to well-justified situations. Major findings from recent genomic studies have impacted the conceptual framework and diagnostic criteria for many disease entities. These changes will have an impact on optimal clinical management. The conclusions of this work are summarized in this report as the proposed International Consensus Classification of mature lymphoid, histiocytic, and dendritic cell tumors.

Advisory Committees↗